Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,156 public trials 552 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention

NCT03643705

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cardiovascular Diseases, +22 more
Locations: Duke Health Durham, North Carolina, United States

University Hospitals Cleveland Medical Center Cleveland, Ohio, United States

MetroHealth Medical Center Cleveland, Ohio, United States

View Trial Details

Completed

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment

NCT01380080

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS Rio de Janeiro, Brazil

Les Centres GHESKIO CRS Port-au-Prince, Haiti

GHESKIO Institute of Infectious Diseases and Reproductive Health (GHESKIO - IMIS) CRS Port-au-Prince, Haiti

YRG CARE Medical Ctr., VHS Chennai CRS Rajiv Gandhi Salai Taramani, Chennai, India

View all 18 locations

View Trial Details

Completed

An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate

NCT03577470

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Azienda Ospedaliera Papa Giovanni XXIII Bergamo, Italy

Azienda Ospedaliera Spedali Civili di Brescia Brescia, Italy

ASST Valle Olona - P.O. di Busto Arsizio Busto Arsizio, Italy

Ente Ospedaliero Ospedeli Galliera Genova, Italy

View all 18 locations

View Trial Details

Completed

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed

NCT05633927

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations: Virgen del Rocio University Hospital Seville, Spain

View Trial Details

Completed

A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults

NCT04871113

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: GSK Investigational Site Long Beach, California, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Orlando, Florida, United States

View all 24 locations

View Trial Details

Completed

A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection

NCT06311734

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Completed

Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis

NCT03620474

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +16 more
Locations: Kohnodai Hospital, National Center for Global Health and Medicine Ichikawa, Chiba, Japan

Tokyo Metropolitan Komagome Hospital Bunkyō-Ku, Tokyo, Japan

Kyushu University Hospital Fukuoka, Japan

View Trial Details

Completed

Couples ART Adherence Intervention for PWID in Kazakhstan

NCT03555396

Conditions: Blood-Borne Infections, Chemically-Induced Disorders, Communicable Diseases, +15 more
Locations: Columbia University Global Health Research Center of Central Asia Almaty, Kazakhstan

View Trial Details

Completed

Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study

NCT04660331

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in Pakistan

NCT06629857

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +19 more
Locations: Darul Sehat Hospital Karachi, Sindh, Pakistan

View Trial Details

Communicable Diseases

Communicable Diseases trial results

Related conditions